カテゴリー： GlobalInfoResearch, 世界

DNAワクチン接種の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global DNA Vaccination Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102922）・商品コード：GIR9102922
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：107
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、DNAワクチン接種の世界市場について調べ、まとめました。種類別セグメントは、ヒトDNAワクチン、動物DNAワクチン等、用途別セグメントは、病院、研究所、学術研究所、その他等に区分しました。DNAワクチン接種の世界市場概観、企業動向、企業別DNAワクチン接種シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・DNAワクチン接種の市場概観
・DNAワクチン接種の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・DNAワクチン接種の企業別販売動向、市場シェア、市場集中度、競争動向
・DNAワクチン接種の世界市場規模
・DNAワクチン接種の北米市場分析（アメリカ、カナダ、メキシコ等）
・DNAワクチン接種のアメリカ市場規模推移
・DNAワクチン接種のカナダ市場規模推移
・DNAワクチン接種のメキシコ市場規模推移
・DNAワクチン接種のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・DNAワクチン接種のドイツ市場規模推移
・DNAワクチン接種のイギリス市場規模推移
・DNAワクチン接種のロシア市場規模推移
・DNAワクチン接種のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・DNAワクチン接種の日本市場規模推移
・DNAワクチン接種の中国市場規模推移
・DNAワクチン接種の韓国市場規模推移
・DNAワクチン接種のインド市場規模推移
・DNAワクチン接種の東南アジア市場規模推移
・DNAワクチン接種の南米市場分析（ブラジル、アルゼンチン等）
・DNAワクチン接種の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・DNAワクチン接種の種類別分析/販売量、売上、市場シェア（ヒトDNAワクチン、動物DNAワクチン）
・DNAワクチン接種の用途別分析/市場規模（病院、研究所、学術研究所、その他）
・DNAワクチン接種の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・DNAワクチン接種の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

DNA vaccination is a technique for protecting against disease by injection with genetically engineered DNA so cells directly produce an antigen, producing a protective immunological response.

Scope of the Report:
The global DNA Vaccination market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of DNA Vaccination.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the DNA Vaccination market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the DNA Vaccination market by product type and applications/end industries.

Market Segment by Companies, this report covers
Inovio Pharmaceuticals
Merck
Astellas Pharma
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Human DNA Vaccines
Animal DNA Vaccines

Market Segment by Applications, can be divided into
Hospitals
Research and Academic Laboratories
Others

【レポートの目次】

Table of Contents

1 DNA Vaccination Market Overview
1.1 Product Overview and Scope of DNA Vaccination
1.2 Classification of DNA Vaccination by Types
1.2.1 Global DNA Vaccination Revenue Comparison by Types (2019-2024)
1.2.2 Global DNA Vaccination Revenue Market Share by Types in 2018
1.2.3 Human DNA Vaccines
1.2.4 Animal DNA Vaccines
1.3 Global DNA Vaccination Market by Application
1.3.1 Global DNA Vaccination Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Research and Academic Laboratories
1.3.4 Others
1.4 Global DNA Vaccination Market by Regions
1.4.1 Global DNA Vaccination Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) DNA Vaccination Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) DNA Vaccination Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) DNA Vaccination Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) DNA Vaccination Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) DNA Vaccination Status and Prospect (2014-2024)
1.5 Global Market Size of DNA Vaccination (2014-2024)
2 Manufacturers Profiles
2.1 Inovio Pharmaceuticals
2.1.1 Business Overview
2.1.2 DNA Vaccination Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Inovio Pharmaceuticals DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 DNA Vaccination Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
2.3 Astellas Pharma
2.3.1 Business Overview
2.3.2 DNA Vaccination Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Astellas Pharma DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 DNA Vaccination Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
3 Global DNA Vaccination Market Competition, by Players
3.1 Global DNA Vaccination Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 DNA Vaccination Players Market Share
3.2.2 Top 10 DNA Vaccination Players Market Share
3.3 Market Competition Trend
4 Global DNA Vaccination Market Size by Regions
4.1 Global DNA Vaccination Revenue and Market Share by Regions
4.2 North America DNA Vaccination Revenue and Growth Rate (2014-2019)
4.3 Europe DNA Vaccination Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific DNA Vaccination Revenue and Growth Rate (2014-2019)
4.5 South America DNA Vaccination Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa DNA Vaccination Revenue and Growth Rate (2014-2019)
5 North America DNA Vaccination Revenue by Countries
5.1 North America DNA Vaccination Revenue by Countries (2014-2019)
5.2 USA DNA Vaccination Revenue and Growth Rate (2014-2019)
5.3 Canada DNA Vaccination Revenue and Growth Rate (2014-2019)
5.4 Mexico DNA Vaccination Revenue and Growth Rate (2014-2019)
6 Europe DNA Vaccination Revenue by Countries
6.1 Europe DNA Vaccination Revenue by Countries (2014-2019)
6.2 Germany DNA Vaccination Revenue and Growth Rate (2014-2019)
6.3 UK DNA Vaccination Revenue and Growth Rate (2014-2019)
6.4 France DNA Vaccination Revenue and Growth Rate (2014-2019)
6.5 Russia DNA Vaccination Revenue and Growth Rate (2014-2019)
6.6 Italy DNA Vaccination Revenue and Growth Rate (2014-2019)
7 Asia-Pacific DNA Vaccination Revenue by Countries
7.1 Asia-Pacific DNA Vaccination Revenue by Countries (2014-2019)
7.2 China DNA Vaccination Revenue and Growth Rate (2014-2019)
7.3 Japan DNA Vaccination Revenue and Growth Rate (2014-2019)
7.4 Korea DNA Vaccination Revenue and Growth Rate (2014-2019)
7.5 India DNA Vaccination Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia DNA Vaccination Revenue and Growth Rate (2014-2019)
8 South America DNA Vaccination Revenue by Countries
8.1 South America DNA Vaccination Revenue by Countries (2014-2019)
8.2 Brazil DNA Vaccination Revenue and Growth Rate (2014-2019)
8.3 Argentina DNA Vaccination Revenue and Growth Rate (2014-2019)
8.4 Colombia DNA Vaccination Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue DNA Vaccination by Countries
9.1 Middle East and Africa DNA Vaccination Revenue by Countries (2014-2019)
9.2 Saudi Arabia DNA Vaccination Revenue and Growth Rate (2014-2019)
9.3 UAE DNA Vaccination Revenue and Growth Rate (2014-2019)
9.4 Egypt DNA Vaccination Revenue and Growth Rate (2014-2019)
9.5 Nigeria DNA Vaccination Revenue and Growth Rate (2014-2019)
9.6 South Africa DNA Vaccination Revenue and Growth Rate (2014-2019)
10 Global DNA Vaccination Market Segment by Type
10.1 Global DNA Vaccination Revenue and Market Share by Type (2014-2019)
10.2 Global DNA Vaccination Market Forecast by Type (2019-2024)
10.3 Human DNA Vaccines Revenue Growth Rate (2014-2024)
10.4 Animal DNA Vaccines Revenue Growth Rate (2014-2024)
11 Global DNA Vaccination Market Segment by Application
11.1 Global DNA Vaccination Revenue Market Share by Application (2014-2019)
11.2 DNA Vaccination Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Research and Academic Laboratories Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global DNA Vaccination Market Size Forecast (2019-2024)
12.1 Global DNA Vaccination Market Size Forecast (2019-2024)
12.2 Global DNA Vaccination Market Forecast by Regions (2019-2024)
12.3 North America DNA Vaccination Revenue Market Forecast (2019-2024)
12.4 Europe DNA Vaccination Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific DNA Vaccination Revenue Market Forecast (2019-2024)
12.6 South America DNA Vaccination Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa DNA Vaccination Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure DNA Vaccination Picture
Table Product Specifications of DNA Vaccination
Table Global DNA Vaccination and Revenue (Million USD) Market Split by Product Type
Figure Global DNA Vaccination Revenue Market Share by Types in 2018
Figure Human DNA Vaccines Picture
Figure Animal DNA Vaccines Picture
Table Global DNA Vaccination Revenue (Million USD) by Application (2014-2024)
Figure DNA Vaccination Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Research and Academic Laboratories Picture
Figure Others Picture
Table Global Market DNA Vaccination Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America DNA Vaccination Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe DNA Vaccination Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific DNA Vaccination Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America DNA Vaccination Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa DNA Vaccination Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global DNA Vaccination Revenue (Million USD) and Growth Rate (2014-2024)
Table Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Inovio Pharmaceuticals DNA Vaccination Type and Applications
Table Inovio Pharmaceuticals DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck DNA Vaccination Type and Applications
Table Merck DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma DNA Vaccination Type and Applications
Table Astellas Pharma DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer DNA Vaccination Type and Applications
Table Pfizer DNA Vaccination Revenue, Gross Margin and Market Share (2017-2018)
Table Global DNA Vaccination Revenue (Million USD) by Players (2014-2019)
Table Global DNA Vaccination Revenue Share by Players (2014-2019)
Figure Global DNA Vaccination Revenue Share by Players in 2017
Figure Global DNA Vaccination Revenue Share by Players in 2018
Figure Global Top 5 Players DNA Vaccination Revenue Market Share in 2018
Figure Global Top 10 Players DNA Vaccination Revenue Market Share in 2018
Figure Global DNA Vaccination Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global DNA Vaccination Revenue (Million USD) by Regions (2014-2019)
Table Global DNA Vaccination Revenue Market Share by Regions (2014-2019)
Figure Global DNA Vaccination Revenue Market Share by Regions (2014-2019)
Figure Global DNA Vaccination Revenue Market Share by Regions in 2018
Figure North America DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Europe DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure South America DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa DNA Vaccination Revenue and Growth Rate (2014-2019)
Table North America DNA Vaccination Revenue by Countries (2014-2019)
Table North America DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure North America DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure North America DNA Vaccination Revenue Market Share by Countries in 2018
Figure USA DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Canada DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Mexico DNA Vaccination Revenue and Growth Rate (2014-2019)
Table Europe DNA Vaccination Revenue (Million USD) by Countries (2014-2019)
Figure Europe DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure Europe DNA Vaccination Revenue Market Share by Countries in 2018
Figure Germany DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure UK DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure France DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Russia DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Italy DNA Vaccination Revenue and Growth Rate (2014-2019)
Table Asia-Pacific DNA Vaccination Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific DNA Vaccination Revenue Market Share by Countries in 2018
Figure China DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Japan DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Korea DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure India DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Southeast Asia DNA Vaccination Revenue and Growth Rate (2014-2019)
Table South America DNA Vaccination Revenue by Countries (2014-2019)
Table South America DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure South America DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure South America DNA Vaccination Revenue Market Share by Countries in 2018
Figure Brazil DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Argentina DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Colombia DNA Vaccination Revenue and Growth Rate (2014-2019)
Table Middle East and Africa DNA Vaccination Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa DNA Vaccination Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa DNA Vaccination Revenue Market Share by Countries in 2018
Figure Saudi Arabia DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure UAE DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Egypt DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure Nigeria DNA Vaccination Revenue and Growth Rate (2014-2019)
Figure South Africa DNA Vaccination Revenue and Growth Rate (2014-2019)
Table Global DNA Vaccination Revenue (Million USD) by Type (2014-2019)
Table Global DNA Vaccination Revenue Share by Type (2014-2019)
Figure Global DNA Vaccination Revenue Share by Type (2014-2019)
Figure Global DNA Vaccination Revenue Share by Type in 2019
Table Global DNA Vaccination Revenue Forecast by Type (2019-2024)
Figure Global DNA Vaccination Market Share Forecast by Type (2019-2024)
Figure Global Human DNA Vaccines Revenue Growth Rate (2014-2019)
Figure Global Animal DNA Vaccines Revenue Growth Rate (2014-2019)
Table Global DNA Vaccination Revenue by Application (2014-2019)
Table Global DNA Vaccination Revenue Share by Application (2014-2019)
Figure Global DNA Vaccination Revenue Share by Application (2014-2019)
Figure Global DNA Vaccination Revenue Share by Application in 2019
Table Global DNA Vaccination Revenue Forecast by Application (2019-2024)
Figure Global DNA Vaccination Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Research and Academic Laboratories Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global DNA Vaccination Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global DNA Vaccination Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global DNA Vaccination Revenue Market Share Forecast by Regions (2019-2024)
Figure North America DNA Vaccination Revenue Market Forecast (2019-2024)
Figure Europe DNA Vaccination Revenue Market Forecast (2019-2024)
Figure Asia-Pacific DNA Vaccination Revenue Market Forecast (2019-2024)
Figure South America DNA Vaccination Revenue Market Forecast (2019-2024)
Figure Middle East and Africa DNA Vaccination Revenue Market Forecast (2019-2024)


【掲載企業】

Inovio Pharmaceuticals、Merck、Astellas Pharma、Pfizer、

★調査レポート[DNAワクチン接種の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102922)販売に関する免責事項を必ずご確認ください。
★調査レポート[DNAワクチン接種の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • アリスキレンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101829 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、アリスキレンの世界市場について調べ、まとめました。種類別セグメントは、150mg錠、300mg錠等、用途別セグメントは、病院、ドラッグストア等に区分しました。アリスキレンの世界市場概観、企業動向、企業別アリスキレンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アリスキレンの市場概観 ・アリスキレンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アリスキレンの企業別販売動向、市場シェア、市場集中度、競争動向 ・アリスキレンの世界市場規模 ・アリスキレンの北米市場分析（アメリカ、カナダ、メキシコ等） ・アリスキレンのアメリカ市場規模推移 ・アリスキレンのカナダ市場規模推移 ・アリスキレンのメキシコ市場規模推移 ・アリスキレンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension. Scope of the Report: The global Aliskiren market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...
  • アニデュラファンギンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101823 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、アニデュラファンギンの世界市場について調べ、まとめました。種類別セグメントは、バイアルあたり50 mg、バイアルあたり100 mg等、用途別セグメントは、病院、ドラッグストア等に区分しました。アニデュラファンギンの世界市場概観、企業動向、企業別アニデュラファンギンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アニデュラファンギンの市場概観 ・アニデュラファンギンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アニデュラファンギンの企業別販売動向、市場シェア、市場集中度、競争動向 ・アニデュラファンギンの世界市場規模 ・アニデュラファンギンの北米市場分析（アメリカ、カナダ、メキシコ等） ・アニデュラファンギンのアメリカ市場規模推移 ・アニデュラファンギンのカナダ市場規模推移...Anidulafungin (INN) (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366. It may also have application in treating invasive Aspergillus infection. Scope of the Report: The global Anidulafungin market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still...
  • ヒストリンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101833 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、ヒストリンの世界市場について調べ、まとめました。種類別セグメントは、サプレリンLA、ヴァンタス等、用途別セグメントは、少年用、少女用等に区分しました。ヒストリンの世界市場概観、企業動向、企業別ヒストリンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ヒストリンの市場概観 ・ヒストリンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ヒストリンの企業別販売動向、市場シェア、市場集中度、競争動向 ・ヒストリンの世界市場規模 ・ヒストリンの北米市場分析（アメリカ、カナダ、メキシコ等） ・ヒストリンのアメリカ市場規模推移 ・ヒストリンのカナダ市場規模推移 ・ヒストリンのメキシコ市場規模推移 ・ヒストリンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Histrelin acetate, sold under the brand names Vantas and Supprelin LA among others, is a nonapeptide analogue of gonadotropin-releasing hormone (GnRH) with added potency. When present in the bloodstream, it acts on particular cells of the pituitary gland called gonadotropes. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist. Scope of the Report: The global Histrelin market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and...
  • ラパチニブの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101874 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、ラパチニブの世界市場について調べ、まとめました。種類別セグメントは、250mg錠、タイプII等、用途別セグメントは、病院、薬局等に区分しました。ラパチニブの世界市場概観、企業動向、企業別ラパチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ラパチニブの市場概観 ・ラパチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ラパチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ラパチニブの世界市場規模 ・ラパチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ラパチニブのアメリカ市場規模推移 ・ラパチニブのカナダ市場規模推移 ・ラパチニブのメキシコ市場規模推移 ・ラパチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours. Scope of the Report: The global Lapatinib market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role...
  • ルビプロストンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101821 / GlobalInfoResearch / 2019年9月13日 / 本調査レポートは、ルビプロストンの世界市場について調べ、まとめました。種類別セグメントは、8 mcgカプセル、24 mcgカプセル等、用途別セグメントは、CICおよびOIC、IBS-C等に区分しました。ルビプロストンの世界市場概観、企業動向、企業別ルビプロストンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ルビプロストンの市場概観 ・ルビプロストンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ルビプロストンの企業別販売動向、市場シェア、市場集中度、競争動向 ・ルビプロストンの世界市場規模 ・ルビプロストンの北米市場分析（アメリカ、カナダ、メキシコ等） ・ルビプロストンのアメリカ市場規模推移 ・ルビプロストンのカナダ市場規模推移...Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. Scope of the Report: The global Lubiprostone market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still...
  • 免疫沈降の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101380 / GlobalInfoResearch / 2019年9月11日 / 本調査レポートは、免疫沈降の世界市場について調べ、まとめました。種類別セグメントは、インディビジュアルIP、免疫共沈降、CHIP等、用途別セグメントは、学術、研究機関、製薬およびバイオテクノロジー企業等に区分しました。免疫沈降の世界市場概観、企業動向、企業別免疫沈降シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・免疫沈降の市場概観 ・免疫沈降の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・免疫沈降の企業別販売動向、市場シェア、市場集中度、競争動向 ・免疫沈降の世界市場規模 ・免疫沈降の北米市場分析（アメリカ、カナダ、メキシコ等） ・免疫沈降のアメリカ市場規模推移 ・免疫沈降のカナダ市場規模推移 ・免疫沈降のメキシコ市場規模推移 ・免疫沈降のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The immunoprecipitation is segmented into individual IP, co-IP, ChIP, and RIP. The increasing use of IP in studying protein-protein interaction, to detect the presence of an antigen, and to determine the relative quantity of an antigen are driving the use of individual IP in various research studies. Scope of the Report: The global Immunoprecipitation market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,...

    • ◆H&Iグローバルリサーチのお客様（例）◆